Baudax Bio Inc expected to post earnings of $1.48 a share - Earnings Preview

Baudax Bio

11/03/2022 23:47

* Baudax Bio Inc  BXRX.OQ   BXRX.O  is expected to show a
rise in
quarterly revenue when it reports  results on March 13
(estimated). 
    * The Malvern Pennsylvania-based  company is expected to
report  a
722.4% increase in revenue to $625 thousand from $76 thousand a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Baudax Bio Inc is
for
earnings of $1.48 per share. For the same quarter last year, the
company reported a loss of $19.25 per share.
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Baudax Bio
Inc is
$44.5​, above​ its last closing price of $1.64. ​​​

This summary was machine generated March 11 at 23:47 GMT.  All
figures in US dollars  unless otherwise stated